drugset / Trial / NCT00563862

Benefit of Adding Chemotherapy And/Or Modification of Radiotherapy Schedule for Advance Nasopharyngeal Carcinoma (T3-4N0-1M0)

NCT00563862

RandomizedFactorialOpen-labelTreatment

Summary

To test the therapeutic ratio of accelerated radiotherapy and/or chemotherapy on locally advanced nasopharyngeal carcinoma.

Timeline

Start
1999-07
Primary completion
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified
Subject fluorouracil Small molecule